Acceptability and usability of smartphone-based brainwave entrainment technology used by individuals with chronic pain in a home setting.
EEG phase synchronisation
Mobile applications
alpha rhythm
pain management
pain perception
Journal
British journal of pain
ISSN: 2049-4637
Titre abrégé: Br J Pain
Pays: England
ID NLM: 101583844
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
entrez:
14
9
2020
pubmed:
15
9
2020
medline:
15
9
2020
Statut:
ppublish
Résumé
Brainwave entrainment (BWE) using rhythmic visual or auditory stimulation has many potential clinical applications, including the management of chronic pain, where there is a pressing need for novel, safe and effective treatments. The aim of this study was to gain qualitative feedback on the acceptability and usability of a novel BWE smartphone application, to ensure it meets the needs and wishes of end users. Fifteen participants with chronic pain used the application at home for 4 weeks. Semi-structured telephone interviews were then carried out. A template analysis approach was used to interpret the findings, with an initial coding template structured around the constructs of a theoretical framework for assessing acceptability of healthcare interventions. Structured data analysis generated a final modified coding structure, capturing themes generated across participants' accounts. The four main themes were 'approach to trying out the app: affective attitude and ethicality', 'perceived effectiveness', 'opportunity costs and burden' and 'intervention coherence and self-efficacy'. All participants were willing to engage with the technology and welcomed it as an alternative approach to medications. Participants appreciated the simplicity of design and the ability to choose between visual or auditory stimulation. All the participants felt confident in using the application. The findings demonstrate preliminary support for the acceptability and usability of the BWE application. This is the first qualitative study of BWE to systematically assess these issues.
Sections du résumé
BACKGROUND
BACKGROUND
Brainwave entrainment (BWE) using rhythmic visual or auditory stimulation has many potential clinical applications, including the management of chronic pain, where there is a pressing need for novel, safe and effective treatments. The aim of this study was to gain qualitative feedback on the acceptability and usability of a novel BWE smartphone application, to ensure it meets the needs and wishes of end users.
METHODS
METHODS
Fifteen participants with chronic pain used the application at home for 4 weeks. Semi-structured telephone interviews were then carried out. A template analysis approach was used to interpret the findings, with an initial coding template structured around the constructs of a theoretical framework for assessing acceptability of healthcare interventions. Structured data analysis generated a final modified coding structure, capturing themes generated across participants' accounts.
RESULTS
RESULTS
The four main themes were 'approach to trying out the app: affective attitude and ethicality', 'perceived effectiveness', 'opportunity costs and burden' and 'intervention coherence and self-efficacy'. All participants were willing to engage with the technology and welcomed it as an alternative approach to medications. Participants appreciated the simplicity of design and the ability to choose between visual or auditory stimulation. All the participants felt confident in using the application.
CONCLUSION
CONCLUSIONS
The findings demonstrate preliminary support for the acceptability and usability of the BWE application. This is the first qualitative study of BWE to systematically assess these issues.
Identifiants
pubmed: 32922777
doi: 10.1177/2049463720908798
pii: 10.1177_2049463720908798
pmc: PMC7453483
doi:
Types de publication
Journal Article
Langues
eng
Pagination
161-170Informations de copyright
© The British Pain Society 2020.
Déclaration de conflit d'intérêts
Conflict of interest: The author(s) declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.
Références
Eur J Pain. 2018 Mar;22(3):538-550
pubmed: 29139226
J Med Internet Res. 2020 Jun 5;22(6):e17457
pubmed: 32501271
Sci Rep. 2017 Mar 03;7:41908
pubmed: 28256510
Front Psychiatry. 2015 May 12;6:70
pubmed: 26029120
Br J Anaesth. 2013 Jul;111(1):13-8
pubmed: 23794640
Curr Pain Headache Rep. 2017 Jan;21(1):2
pubmed: 28097532
Neuroimage. 2012 Sep;62(3):1965-74
pubmed: 22659486
Int J Behav Nutr Phys Act. 2014 Jul 25;11:97
pubmed: 25059981
Br J Pain. 2016 Aug;10(3):135-40
pubmed: 27583140
Spinal Cord. 2008 Feb;46(2):118-23
pubmed: 17502876
Front Hum Neurosci. 2016 Mar 14;10:111
pubmed: 27014041
Spinal Cord. 2013 Jan;51(1):55-8
pubmed: 22801188
Best Pract Res Clin Rheumatol. 2017 Apr;31(2):160-168
pubmed: 29224694
Prev Med. 2019 Jan;118:171-175
pubmed: 30315848
Brain. 2006 Jan;129(Pt 1):55-64
pubmed: 16183660
Trends Cogn Sci. 2012 Dec;16(12):606-17
pubmed: 23141428
Drug Alcohol Depend. 2017 Apr 01;173 Suppl 1:S11-S21
pubmed: 28363315
BMC Public Health. 2013 Dec 24;13:1229
pubmed: 24365383
Neuron. 2019 Mar 20;101(6):1029-1041
pubmed: 30897355
Arthritis Rheum. 2007 Apr;56(4):1345-54
pubmed: 17393440
Arthritis Rheum. 2010 Oct;62(10):2930-40
pubmed: 20518076
J Pain. 2008 Mar;9(3):193-9
pubmed: 18096437
J Pain Res. 2013 Nov 25;6:815-24
pubmed: 24379694
J Dent Educ. 2001 Dec;65(12):1378-82
pubmed: 11780656
Neuroimage. 2006 Jul 1;31(3):1268-77
pubmed: 16529953
BMC Health Serv Res. 2017 Jan 26;17(1):88
pubmed: 28126032
Eur J Pain. 2017 Mar;21(3):562-572
pubmed: 27807916
JAMA. 2002 Nov 20;288(19):2469-75
pubmed: 12435261
Qual Res Psychol. 2015 Apr 3;12(2):202-222
pubmed: 27499705
PLoS One. 2013 Oct 11;8(10):e78278
pubmed: 24147129
Pain. 2010 Mar;148(3):359-60
pubmed: 20080346
Neuroimage. 2009 Jul 15;46(4):1082-90
pubmed: 19327401
Eur J Pain. 2005 Aug;9(4):463-84
pubmed: 15979027
Pain Med. 2017 Oct 1;18(10):1921-1931
pubmed: 28087845
J Pain. 2018 Jul;19(7):807-818
pubmed: 29551661
Prog Neurobiol. 2009 Feb;87(2):81-97
pubmed: 18952143
BMJ Open. 2018 Jun 6;8(6):e019491
pubmed: 29880563
J Pain. 2019 Mar;20(3):277.e1-277.e11
pubmed: 30268803
Aust N Z J Public Health. 2007 Oct;31(5):433-7
pubmed: 17931290
J Pain. 2012 Aug;13(8):715-24
pubmed: 22607834
Transl Behav Med. 2017 Jun;7(2):292-299
pubmed: 28527027
J Pain. 2006 Oct;7(10):709-17
pubmed: 17018331
Am J Med. 2016 Jan;129(1):11-9
pubmed: 26091764
Hum Brain Mapp. 2016 Feb;37(2):501-14
pubmed: 26523484
Eur J Neurosci. 2005 Dec;22(11):2917-26
pubmed: 16324126
Br J Pharmacol. 2018 Jul;175(14):2778-2790
pubmed: 28449262
PLoS One. 2014 Sep 02;9(9):e106133
pubmed: 25180885